IMVT
Immunovant, Inc. · Healthcare
Chief Dev., Tech. Officer Julia G. Butchko sold $38K of Immunovant, Inc.
Sold$37,648
$5.90Price
6,381Shares
−2%Stake
What IMVT did after the filing
- The stock from Thu, Apr 14 open, $5.09
- −17.1%
- S&P 500, same days
- −6.4%
Measured over 30 trading days, to the May 27 close.
Traded Thu, Mar 24. Filed Thu, Apr 14, 3:18 AM ET, before the open. Returns use the Apr 14 open and the May 27 close. Not investment advice.